1. Home
  2. AUB vs COGT Comparison

AUB vs COGT Comparison

Compare AUB & COGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlantic Union Bankshares Corporation

AUB

Atlantic Union Bankshares Corporation

HOLD

Current Price

$42.56

Market Cap

6.0B

Sector

Finance

ML Signal

HOLD

Logo Cogent Biosciences Inc.

COGT

Cogent Biosciences Inc.

HOLD

Current Price

$37.89

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUB
COGT
Founded
1902
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
6.6B
IPO Year
2005
2018

Fundamental Metrics

Financial Performance
Metric
AUB
COGT
Price
$42.56
$37.89
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
15
Target Price
$41.88
$36.21
AVG Volume (30 Days)
941.1K
1.8M
Earning Date
04-21-2026
05-06-2026
Dividend Yield
3.98%
N/A
EPS Growth
N/A
N/A
EPS
1.95
N/A
Revenue
N/A
$7,871,000.00
Revenue This Year
$29.16
N/A
Revenue Next Year
$4.59
$1,733.58
P/E Ratio
$21.99
N/A
Revenue Growth
N/A
N/A
52 Week Low
$30.87
$11.53
52 Week High
$43.62
$43.73

Technical Indicators

Market Signals
Indicator
AUB
COGT
Relative Strength Index (RSI) 55.06 44.22
Support Level $40.74 $36.53
Resistance Level $43.58 $40.67
Average True Range (ATR) 0.71 1.99
MACD -0.07 -0.54
Stochastic Oscillator 70.01 17.60

Price Performance

Historical Comparison
AUB
COGT

About AUB Atlantic Union Bankshares Corporation

Atlantic Union Bankshares Corp is a financial and bank holding company based in the U.S. Through its community bank subsidiary and non-bank financial services affiliates, the company provides financial services, including banking, trust, and wealth management. It offers consumers and businesses a wide range of banking and related financial services, including checking, savings, certificates of deposit, and other depository services, as well as loans for commercial, industrial, residential mortgage, and consumer purposes. The company operates through two reportable operating segments: Wholesale Banking and Consumer Banking, with corporate support functions such as corporate treasury and others included in Corporate Other. It derives maximum revenue from the Wholesale Banking segment.

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

Share on Social Networks: